On October 15, 2026, MolDx announced it was canceling its draft non-coverage LCD for Prelude's DCISionRT. This follows recent announcements (1) first, the draft would be delayed and (2) and second, a CAC meeting 10/13 on the topic.
See message from CEO here.
I have updated my September 21 blog to keep the storyline in one place.
https://www.discoveriesinhealthpolicy.com/2026/09/when-does-moldx-change-its-mind-prelude.html
